Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Miranda L G, Hallquist"'
Autor:
Juliann M. Savatt, Nicole M. Ortiz, Gretchen M. Thone, Whitney S. McDonald, Melissa A. Kelly, Alexander S. F. Berry, Madiha M. Alvi, Miranda L. G. Hallquist, Jennifer Malinowski, Nicholas C. Purdy, Marc S. Williams, Amy C. Sturm, Adam H. Buchanan
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-15 (2022)
Abstract Background In current care, patients’ personal and self-reported family histories are primarily used to determine whether genetic testing for hereditary endocrine tumor syndromes (ETS) is indicated. Population genomic screening for other c
Externí odkaz:
https://doaj.org/article/b1bdba2497124f9699e8abe03f4b831d
Autor:
Laney K. Jones, Natasha T. Strande, Evan M. Calvo, Jingheng Chen, Gabriela Rodriguez, Cara Z. McCormick, Miranda L. G. Hallquist, Juliann M. Savatt, Heather Rocha, Marc S. Williams, Amy C. Sturm, Adam H. Buchanan, Russell E. Glasgow, Christa L. Martin, Alanna Kulchak Rahm
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Introduction: DNA-based population screening has been proposed as a public health solution to identify individuals at risk for serious health conditions who otherwise may not present for medical care. The clinical utility and public health impact of
Externí odkaz:
https://doaj.org/article/522103d74d794e618ecf78894398352a
Autor:
Miranda L. G. Hallquist, Eric P. Tricou, Kelly E. Ormond, Juliann M. Savatt, Curtis R. Coughlin, W. Andrew Faucett, Laura Hercher, Howard P. Levy, Julianne M. O’Daniel, Holly L. Peay, Melissa Stosic, Maureen Smith, Wendy R. Uhlmann, Hannah Wand, Karen E. Wain, Adam H. Buchanan
Publikováno v:
Genome Medicine, Vol 13, Iss 1, Pp 1-12 (2021)
Abstract Background Genetic information is increasingly relevant across healthcare. Traditional genetic counseling (GC) may limit access to genetic information and may be more information and support than some individuals need. We report on the appli
Externí odkaz:
https://doaj.org/article/348a4e111572441990f3d9d19a060b20
Autor:
Cara Zayac McCormick, Kristen Dilzell Yu, Alicia Johns, Gemme Campbell-Salome, Miranda L. G. Hallquist, Amy C. Sturm, Adam H. Buchanan
Publikováno v:
Journal of Personalized Medicine; Volume 12; Issue 12; Pages: 1943
Genomic screening programs have potential to benefit individuals who may not be clinically ascertained, but little is known about the psychological impact of receiving genetic results in this setting. The current study sought to further the understan
Autor:
Workgroup, Kelly E. Ormond, Maia J. Borensztein, Miranda L. G. Hallquist, Adam H. Buchanan, William Andrew Faucett, Holly L. Peay, Maureen E. Smith, Eric P. Tricou, Wendy R. Uhlmann, Karen E. Wain, Curtis R. Coughlin, On behalf of the Clinical Genome CADRe Workgroup On behalf of the Clinical Genome CADRe
Publikováno v:
Journal of Personalized Medicine; Volume 11; Issue 12; Pages: 1304
Purpose: Informed consent for genetic testing has historically been acquired during pretest genetic counseling, without specific guidance defining which core concepts are required. Methods: The Clinical Genome Resource (ClinGen) Consent and Disclosur
Autor:
Kelly E. Ormond, Maia J. Borensztein, Miranda L. G. Hallquist, Adam H. Buchanan, William Andrew Faucett, Holly L. Peay, Maureen E. Smith, Eric P. Tricou, Wendy R. Uhlmann, Karen E. Wain, Curtis R. Coughlin, On behalf of the Clinical Genome CADRe Workgroup
Publikováno v:
Journal of Personalized Medicine, Vol 11, Iss 1304, p 1304 (2021)
Purpose: Informed consent for genetic testing has historically been acquired during pretest genetic counseling, without specific guidance defining which core concepts are required. Methods: The Clinical Genome Resource (ClinGen) Consent and Disclosur
Autor:
Miranda L G, Hallquist, Eric P, Tricou, Michael N, Hallquist, Juliann M, Savatt, Heather, Rocha, Alyson E, Evans, Nicole, Deckard, Yirui, Hu, H Lester, Kirchner, Josie, Pervola, Alanna Kulchak, Rahm, Misha, Rashkin, Tara J, Schmidlen, Marci L B, Schwartz, Janet L, Williams, Marc S, Williams, Adam H, Buchanan
Publikováno v:
Genetics in medicine : official journal of the American College of Medical Genetics. 22(8)
Cancer genetics clinics have seen increasing demand, challenging genetic counselors (GCs) to increase efficiency and prompting some clinics to implement genetic counseling assistants (GCAs). To evaluate the impact of GCAs on Geisinger's cancer geneti
Autor:
Williams MS; Marc S. Williams ( mswilliams1@geisinger.edu ) is director of the Genomic Medicine Institute, Geisinger, in Danville, Pennsylvania., Buchanan AH; Adam H. Buchanan is an assistant professor at the Genomic Medicine Institute, Geisinger., Davis FD; F. Daniel Davis is director of the Center for Bioethics and Healthcare Policy, Geisinger., Faucett WA; W. Andrew Faucett is a professor at the Genomic Medicine Institute, Geisinger., Hallquist MLG; Miranda L. G. Hallquist is a genetic counselor at the Genomic Medicine Institute, Geisinger., Leader JB; Joseph B. Leader is director of the Phenomic Analytics and Clinical Data Core, Geisinger., Martin CL; Christa L. Martin is director of the Autism and Developmental Medicine Institute, Geisinger., McCormick CZ; Cara Z. McCormick is a senior assistant at the Genomic Medicine Institute, Geisinger., Meyer MN; Michelle N. Meyer is associate director for research ethics at the Center for Translational Bioethics and Health Care Policy, Geisinger., Murray MF; Michael F. Murray was a physician in the Genomic Medicine Institute, Geisinger, at the time this work was completed. He is now at the Yale School of Medicine., Rahm AK; Alanna K. Rahm is an assistant professor at the Genomic Medicine Institute, Geisinger., Schwartz MLB; Marci L. B. Schwartz is a genetic counselor at the Genomic Medicine Institute, Geisinger., Sturm AC; Amy C. Sturm is a professor at the Genomic Medicine Institute, Geisinger., Wagner JK; Jennifer K. Wagner is associate director of bioethics research, Center for Translational Bioethics and Health Care Policy, Geisinger., Williams JL; Janet L. Williams is director of research genetic counselors, Genomic Medicine Institute, Geisinger., Willard HF; Huntington F. Willard is director of the National Precision Health Institute, Geisinger., Ledbetter DH; David H. Ledbetter is executive vice president and chief scientific officer, Geisinger.
Publikováno v:
Health affairs (Project Hope) [Health Aff (Millwood)] 2018 May; Vol. 37 (5), pp. 757-764.